LT3618821T - Nefrogeninio necukrinio diabeto valdymas - Google Patents
Nefrogeninio necukrinio diabeto valdymasInfo
- Publication number
- LT3618821T LT3618821T LTEPPCT/US2018/016184T LTUS2018016184T LT3618821T LT 3618821 T LT3618821 T LT 3618821T LT US2018016184 T LTUS2018016184 T LT US2018016184T LT 3618821 T LT3618821 T LT 3618821T
- Authority
- LT
- Lithuania
- Prior art keywords
- insulication
- management
- nephrogenic diabetes
- nephrogenic
- diabetes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762452616P | 2017-01-31 | 2017-01-31 | |
| PCT/US2018/016184 WO2018144570A1 (en) | 2017-01-31 | 2018-01-31 | Managing nephrogenic diabetes insipidus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3618821T true LT3618821T (lt) | 2025-05-26 |
Family
ID=63040033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/US2018/016184T LT3618821T (lt) | 2017-01-31 | 2018-01-31 | Nefrogeninio necukrinio diabeto valdymas |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US11179354B2 (lt) |
| EP (1) | EP3618821B8 (lt) |
| AU (1) | AU2018217038B2 (lt) |
| CA (1) | CA3071385A1 (lt) |
| DK (1) | DK3618821T3 (lt) |
| ES (1) | ES3024479T3 (lt) |
| FI (1) | FI3618821T3 (lt) |
| HR (1) | HRP20250377T1 (lt) |
| HU (1) | HUE071486T2 (lt) |
| LT (1) | LT3618821T (lt) |
| PL (1) | PL3618821T3 (lt) |
| PT (1) | PT3618821T (lt) |
| SI (1) | SI3618821T1 (lt) |
| WO (1) | WO2018144570A1 (lt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9827222B2 (en) | 2013-07-01 | 2017-11-28 | Emory University | Treating or preventing nephrogenic diabetes insipidus |
| PT3618821T (pt) | 2017-01-31 | 2025-05-14 | Nephrodi Therapeutics Inc | Manejo da diabetes insípida nefrogénica |
| WO2022081858A1 (en) * | 2020-10-14 | 2022-04-21 | Emory University | Methods of managing side effects of a vasopressin receptor antagonist therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5864381A (en) | 1996-07-10 | 1999-01-26 | Sandia Corporation | Automated pupil remapping with binary optics |
| HUE036646T2 (hu) | 2003-01-23 | 2018-07-30 | Esperion Therapeutics Inc | Hidroxilvegyületek és kompozícióik koleszterin szabályozására és kapcsolódó alkalmazásokra |
| US20090297497A1 (en) * | 2004-10-25 | 2009-12-03 | Kishore Bellamkonda K | Methods and compositions for treating nephrogenic diabetes and insipidus |
| CA2812109A1 (en) * | 2010-09-20 | 2012-03-29 | Kareus Therapeutics, Sa | Methods and compositions for treatment of diabetes and dyslipidemia |
| US20140121267A1 (en) | 2011-09-20 | 2014-05-01 | Kareus Therapeutics, Sa | Methods and compositions for treatment of diabetes and dyslipidemia |
| US9827222B2 (en) | 2013-07-01 | 2017-11-28 | Emory University | Treating or preventing nephrogenic diabetes insipidus |
| WO2015101609A1 (en) | 2013-12-31 | 2015-07-09 | Stichting Katholieke Universiteit | Method for treating renal disorders |
| PT3618821T (pt) | 2017-01-31 | 2025-05-14 | Nephrodi Therapeutics Inc | Manejo da diabetes insípida nefrogénica |
-
2018
- 2018-01-31 PT PT187482369T patent/PT3618821T/pt unknown
- 2018-01-31 WO PCT/US2018/016184 patent/WO2018144570A1/en not_active Ceased
- 2018-01-31 EP EP18748236.9A patent/EP3618821B8/en active Active
- 2018-01-31 SI SI201831225T patent/SI3618821T1/sl unknown
- 2018-01-31 CA CA3071385A patent/CA3071385A1/en active Pending
- 2018-01-31 FI FIEP18748236.9T patent/FI3618821T3/fi active
- 2018-01-31 US US16/491,990 patent/US11179354B2/en active Active
- 2018-01-31 HR HRP20250377TT patent/HRP20250377T1/hr unknown
- 2018-01-31 HU HUE18748236A patent/HUE071486T2/hu unknown
- 2018-01-31 LT LTEPPCT/US2018/016184T patent/LT3618821T/lt unknown
- 2018-01-31 ES ES18748236T patent/ES3024479T3/es active Active
- 2018-01-31 DK DK18748236.9T patent/DK3618821T3/da active
- 2018-01-31 AU AU2018217038A patent/AU2018217038B2/en active Active
- 2018-01-31 PL PL18748236.9T patent/PL3618821T3/pl unknown
-
2021
- 2021-10-20 US US17/506,236 patent/US11844770B2/en active Active
-
2023
- 2023-11-06 US US18/502,729 patent/US12433858B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE071486T2 (hu) | 2025-09-28 |
| US20240139127A1 (en) | 2024-05-02 |
| EP3618821A4 (en) | 2021-03-03 |
| US20200383940A1 (en) | 2020-12-10 |
| EP3618821B1 (en) | 2025-03-12 |
| ES3024479T3 (en) | 2025-06-04 |
| SI3618821T1 (sl) | 2025-07-31 |
| DK3618821T3 (da) | 2025-04-07 |
| AU2018217038B2 (en) | 2023-07-06 |
| US12433858B2 (en) | 2025-10-07 |
| PT3618821T (pt) | 2025-05-14 |
| AU2018217038A1 (en) | 2020-07-02 |
| FI3618821T3 (fi) | 2025-06-20 |
| HRP20250377T1 (hr) | 2025-07-18 |
| US11179354B2 (en) | 2021-11-23 |
| PL3618821T3 (pl) | 2025-07-07 |
| WO2018144570A1 (en) | 2018-08-09 |
| EP3618821B8 (en) | 2025-04-23 |
| CA3071385A1 (en) | 2018-08-09 |
| US20220031639A1 (en) | 2022-02-03 |
| EP3618821A1 (en) | 2020-03-11 |
| US11844770B2 (en) | 2023-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256999B (en) | Diabetes management therapy advisor | |
| EP3704685A4 (en) | VERTIPORTS MANAGEMENT PLATFORM | |
| EP3578560A4 (en) | QUINAZOLINE COMPOUND | |
| EP3615661C0 (en) | BI- OR MULTI-DIFFERENTIATED ORGANOID | |
| DK3474804T4 (da) | Medicinsk forbinding | |
| EP3609871A4 (en) | ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS | |
| EP3718392A4 (en) | HARVEST MACHINE | |
| DK3737403T5 (da) | Modificerede adenovira | |
| DK4039675T3 (da) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser | |
| PL3672948T3 (pl) | Związki pirydynoamino-pirydonu i pirymidynoamino-pirydonu | |
| EP3542366C0 (en) | BASIC INSULIN MANAGEMENT | |
| DK3414367T3 (da) | Fosfordoteret siliciumenkeltkrystal | |
| EP3533422C0 (en) | Flat foot orthosis | |
| EP3454846A4 (en) | CRYSTALS | |
| UA38744S (uk) | Монітор | |
| EP3734672A4 (en) | PRODUCTION MANAGEMENT DEVICE | |
| EP2976864A4 (en) | RECOMMENDATIONS | |
| HUE056928T2 (hu) | Új vegyületek | |
| DK3672941T3 (da) | Pyridylpyridonforbindelser | |
| HRP20251697T1 (hr) | Kristalni oblik n-butildeoksigalaktonojirimicina | |
| LT3618821T (lt) | Nefrogeninio necukrinio diabeto valdymas | |
| DK3672962T3 (da) | Morpholinylpyridonforbindelser | |
| DK3672967T3 (da) | Azaindolylpyridon- og diazaindolylpyridonforbindelser | |
| EP3838146A4 (en) | OXYMETER | |
| EP3838145A4 (en) | OXYMETER |